Fundus fluorescein angiography and optical coherence tomography findings in ocular and non-ocular Behҫet’s disease

Zeidan, 2016, Behçet's disease physiopathology: a contemporary review, Auto Immun Highlights, 7, 4, 10.1007/s13317-016-0074-1 Abdel Razek, 2014, Imaging spectrum of CNS vasculitis, Radiographics, 34, 873, 10.1148/rg.344135028 Yazdanpanah, 2018, Is there any association between human T-lymphotropic virus type 1 (HTLV-1) infection and Behcet’s disease?, Rheumatol Res, 3, 129, 10.22631/rr.2018.69997.1054 Greco, 2018, Behçet's disease: new insights into pathophysiology, clinical features and treatment options, Autoimmun Rev., 17, 567, 10.1016/j.autrev.2017.12.006 Ye, 2018, A metagenomic study of the gut microbiome in Behcet's disease, Microbiome, 6, 135, 10.1186/s40168-018-0520-6 McNally, 2017, An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review, Orphanet J Rare Dis, 12, 130, 10.1186/s13023-017-0681-6 Tugal-Tutkun, 2013, Differential diagnosis of Behçet uveitis, Ocul Immunol Inflamm., 21, 337, 10.3109/09273948.2013.795228 Tugal-Tutkun, 2012, Laser flare photometry and its use in uveitis, Expert Rev Ophthalmol, 7, 449, 10.1586/eop.12.47 Kahloun, 2012, Macular involvement in patients with Behçet's uveitis, J Ophthalmic Inflamm Infect, 2, 121, 10.1007/s12348-012-0075-9 Tugal-Tutkun, 2016, Review for diagnostics of the year: multimodal imaging in Behçet uveitis, Ocul Immunol Inflamm., 25, 7, 10.1080/09273948.2016.1205100 Gedik, 2005, Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease, OculImmunol Inflamm, 13, 51 Atmaca, 2003, Fluorescein and indocyanine green angiography findings in Behcet'sdisease, Br J Ophthalmol, 87, 1466, 10.1136/bjo.87.12.1466 Dingerkus, 2019, Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis, J Ophthalmic Inflamm Infect, 9, 10, 10.1186/s12348-019-0176-9 Markomichelakis, 2004, Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography, Ophthalmology, 111, 946, 10.1016/j.ophtha.2003.08.037 Unoki N, Nishijima K, Kita M, HayashiR, Yoshimura N. Structural changes of fovea during remission of Behçet’s disease as imaged by spectral domain optical coherence tomography. Eye 2010; 24:969–75. Sivaprasad, 2007, Tomographic assessment of therapeutic response to uveitic macular oedema, Clin Exp Ophthalmol, 35, 719, 10.1111/j.1442-9071.2007.01577.x Wechsler, 1990, International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease, Lancet, 335, 1078 Jabs, 2005, Standardization of uveitisnomenclature for reporting clinical data. Results of the First International Workshop, Am J Ophthalmol, 140, 509, 10.1016/j.ajo.2005.03.057 Gheita TA, El-Latif EA, El-Gazzar II, Samy N, Hammam N, Egyptian College of Rheumatology-Behçet’s Disease Study Group (ECR-BDSG) et al. Behçet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatol 2019;38(9):2565–75. Umazume, 2018, Evaluation of efficacy of infliximab for retinal vasculitis and extraocular symptoms in Behçet disease, Jpn J Ophthalmol, 62, 390, 10.1007/s10384-018-0589-2 El Garf, 2018, Efficacy of infliximab in refractory posterior uveitis in Behcet's disease patients, Egyptian Rheumatol, 40, 93, 10.1016/j.ejr.2017.08.001 Khalil, 2016, The Effectiveness of intraocular methotrexate in the treatment of posterior uveitis in Behçet's disease patients compared to retrobulbar steroids injection, J Ophthalmol, 2016, 1678495, 10.1155/2016/1678495 Gupta, 2014, Retinal imaging in uveitis, Saudi J Ophthalmol, 28, 95, 10.1016/j.sjopt.2014.02.008 Ozdal, 2002, Posterior segment involvement in ocular Behçet's disease, Eur J Ophthalmol, 12, 424, 10.1177/112067210201200514 Chams, 2015, Ophthalmic findings in Behcet’s disease: cases without apparent ocular signs, J Curr Ophthalmol., 27, 46, 10.1016/j.joco.2015.10.003 Witmer, 2013, Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis(®) noncontact ultra-widefield module versus the Optos(®) Optomap(®), Clin Ophthalmol, 7, 389, 10.2147/OPTH.S41731 Ghoraba, 2018, Fundus fluorescein angiography versus optical coherence tomography angiography in evaluation of retinal changes in cases of retinal vein occlusion, Med J Cairo Univ, 8, 297 Schreur, 2019, Morphological and topographical appearance of microaneurysms on optical coherence tomography angiography, Br J Ophthalmol, 103, 630, 10.1136/bjophthalmol-2018-312258 Bhende, 2018, Optical coherence tomography: a guide to interpretation of common macular, Indian J Ophthalmol, 66, 20, 10.4103/ijo.IJO_902_17 Lee, 2010, Effect of media opacity on retinal nerve fiber layer thickness measurements by optical coherence tomography, J Ophthalmic Vis Res, 5, 151 Öztürk, 2017, Vitreomacular interface disorders in Behçet’s Uveitis, Turk J Ophthalmol, 47, 261, 10.4274/tjo.77632 George, 1997, Ocular immunopathology of Behçet’s disease, Surv Ophthalmol, 42, 157, 10.1016/S0039-6257(97)00026-X Coskun, 2013, Enhanced depth imaging optical coherence tomography findings in Behçet disease, Ocul Immunol Inflamm, 21, 440, 10.3109/09273948.2013.817591 Manjunath, 2010, Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography, Am J Ophthalmol, 150, 325, 10.1016/j.ajo.2010.04.018 Narendran, 2018, Comparison of choroidal thickness using swept-source and spectral-domain optical coherence tomography in normal Indian eyes, Oman J Ophthalmol, 11, 38 Kim, 2013, Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes, Invest Ophthalmol Vis Sci, 54, 6033, 10.1167/iovs.13-12231 Mittal, 2017, Choroidal thickness in non-ocular Behçet's disease – A spectral-domain OCT study, J Curr Ophthalmol, 29, 210, 10.1016/j.joco.2017.06.002